No Data
No Data
Morgan Stanley Maintains Immunocore(IMCR.US) With Buy Rating, Raises Target Price to $80
Morgan Stanley analyst Jeffrey Hung maintains $Immunocore(IMCR.US)$ with a buy rating, and adjusts the target price from $79 to $80.According to TipRanks data, the analyst has a success rate of 57.6%
Morgan Stanley Keeps Their Buy Rating on Immunocore Holdings (IMCR)
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
13 analysts have expressed a variety of opinions on Immunocore Hldgs (NASDAQ:IMCR) over the past quarter, offering a diverse set of opinions from bullish to bearish.In the table below, you'll find a
Immunocore Holdings Price Target Cut to $66.00/Share From $70.00 by JP Morgan
Immunocore Holdings Price Target Cut to $66.00/Share From $70.00 by JP
Express News | JP Morgan Maintains Overweight on Immunocore Hldgs, Lowers Price Target to $66
Express News | Immunocore : JP Morgan Cuts Target Price to $66 From $70